Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)
Clinical trial NCT02728089 · COMPLETED
Trial details
- NCT number
- NCT02728089
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-14
- Primary completion
- 2017-09-05
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.